Education
About Us
Working with TipRanks
Follow Us
Amgen Inc (GB:0R0T)
:0R0T
Total Valuation
Amgen has a market cap or net worth of $148.33B. The enterprise value is $191.48B.
Market Cap$148.33B
Enterprise Value$191.48B
Share Statistics
Amgen has 537,706,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding537,706,100
Owned by Insiders0.22%
Owned by Institutions18.85%
Financial Efficiency
Amgen’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 8.91%.
Return on Equity (ROE)0.70
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)8.91%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee1.19M
Profits Per Employee146.07K
Employee Count28,000
Asset Turnover0.36
Inventory Turnover1.84
Valuation Ratios
The current PE Ratio of Amgen is 34.48. Amgen’s PEG ratio is 0.53.
PE Ratio34.48
PS Ratio0.00
PB Ratio23.04
Price to Fair Value23.99
Price to FCF13.09
Price to Operating Cash Flow11.73
PEG Ratio0.53
Income Statement
In the last 12 months, Amgen had revenue of 33.42B and earned 4.09B in profits. Earnings per share was 7.56.
Revenue33.42B
Gross Profit20.57B
Operating Income7.26B
Pretax Income4.61B
Net Income4.09B
EBITDA13.36B
Earnings Per Share (EPS)7.56
Cash Flow
In the last 12 months, operating cash flow was 12.19B and capital expenditures -1.28B, giving a free cash flow of 10.91B billion.
Operating Cash Flow12.19B
Free Cash Flow10.91B
Free Cash Flow per Share20.30
Dividends & Yields
Amgen pays an annual dividend of $9.26, resulting in a dividend yield of 3.35%
Dividend Per Share$9.26
Dividend Yield3.35%
Payout Ratio44.60%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.39
52-Week Price Change-8.84%
50-Day Moving Average291.09
200-Day Moving Average295.16
Relative Strength Index (RSI)46.84
Average Volume (3m)1.16K
Important Dates
Amgen upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.
Last Earnings DateMay 1, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend DateMay 16, 2025
Financial Position
Amgen as a current ratio of 1.26, with Debt / Equity ratio of 924.46%
Current Ratio1.26
Quick Ratio0.95
Debt to Market Cap0.43
Net Debt to EBITDA3.60
Interest Coverage Ratio2.30
Taxes
In the past 12 months, Amgen has paid 519.00M in taxes.
Income Tax519.00M
Effective Tax Rate0.11
Enterprise Valuation
Amgen EV to EBITDA ratio is 14.16, with an EV/FCF ratio of 18.20.
EV to Sales5.66
EV to EBITDA14.16
EV to Free Cash Flow18.20
EV to Operating Cash Flow16.46
Balance Sheet
Amgen has $8.81B in cash and marketable securities with $57.38B in debt, giving a net cash position of $48.57B billion.
Cash & Marketable Securities$8.81B
Total Debt$57.38B
Net Cash$48.57B
Net Cash Per Share$90.33
Tangible Book Value Per Share-$74.78
Margins
Gross margin is 63.00%, with operating margin of 21.71%, and net profit margin of 12.24%.
Gross Margin63.00%
Operating Margin21.71%
Pretax Margin13.79%
Net Profit Margin12.24%
EBITDA Margin39.96%
EBIT Margin23.23%
Analyst Forecast
The average price target for Amgen is $327.18, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$327.18
Price Target Upside19.08% Upside
Analyst ConsensusModerate Buy
Analyst Count20
Revenue Growth Forecast―
EPS Growth Forecast―